These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15530599)

  • 1. Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey.
    Finney Rutten LJ; Meissner HI; Breen N; Vernon SW; Rimer BK
    Prev Med; 2005 Apr; 40(4):461-8. PubMed ID: 15530599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
    Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
    Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
    Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.
    Han PK; Coates RJ; Uhler RJ; Breen N
    Am J Prev Med; 2006 May; 30(5):394-404. PubMed ID: 16627127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of prostate-specific antigen testing in a large multiethnic cohort.
    Haque R; Van Den Eeden SK; Jacobsen SJ; Caan B; Avila CC; Slezak J; Sternfeld B; Loo RK; Quinn VP
    Am J Manag Care; 2009 Nov; 15(11):793-9. PubMed ID: 19895183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.
    Ross LE; Coates RJ; Breen N; Uhler RJ; Potosky AL; Blackman D
    Prev Med; 2004 Jun; 38(6):732-44. PubMed ID: 15193893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
    Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
    Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
    Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
    Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in prostate-specific antigen testing from 1995 through 2004.
    Farwell WR; Linder JA; Jha AK
    Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer screening among Latino subgroups in the United States.
    Gorin SS; Heck JE
    Prev Med; 2005 May; 40(5):515-26. PubMed ID: 15749133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid.
    Sheridan SL; Felix K; Pignone MP; Lewis CL
    Patient Educ Couns; 2004 Sep; 54(3):345-51. PubMed ID: 15324986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral associations between prostate and colon cancer screening.
    Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
    J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA testing in office-based clinics: are we testing as much as we think?
    González HM; West B; Underwood W
    J Am Coll Surg; 2005 Dec; 201(6):906-12. PubMed ID: 16310694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
    Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
    Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
    Farrell MH; Murphy MA; Schneider CE
    Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intention to test for prostate cancer.
    Berglund G; Nilsson S; Nordin K
    Eur J Cancer; 2005 May; 41(7):990-7. PubMed ID: 15862747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.